Figure 1 — Zinc oxide nanoparticles (ZnO NPs) combined with cisplatin and gemcitabine inhibits tumor activity of NSCLC cells

Research Paper|Volume 12, Issue 24|pp. 25767–25777

Zinc oxide nanoparticles (ZnO NPs) combined with cisplatin and gemcitabine inhibits tumor activity of NSCLC cells

100%

Figure 1.Physicochemical property of ZnO NPs(Cp/Gem). (A) The morphologies of ZnO NPs(Cp/Gem) by transmission electron microscopy. (B) Size distributions of ZnO NPs(Cp/Gem) determined by dynamic light scattering at 0 and 48 h.